Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Voulgaris (Alexandroupolis, Greece), K. Archontogeorgis (Alexandroupolis, Greece), E. Nena (Alexandroupolis, Greece), M. Xanthoudaki (Alexandroupolis, Greece), P. Ntolios (Alexandroupolis, Greece), T. Mouemin (Alexandroupolis, Greece), K. Chadia (Alexandroupolis, Greece), N. Paxinou (Alexandroupolis, Greece), K. Kaltsas (Alexandroupolis, Greece), M. Froudarakis (Alexandroupolis, Greece), P. Steiropoulos (Alexandroupolis, Greece). Assessment of 10-year risk for cardiovascular disease in patients with overlap syndrome. 2502

Member's Comments

No comment yet.

Related content which might interest you: Global cardiovascular disease risk in U.S. adults by severity and presence of COPD Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Global cardiovascular disease risk score among U.S. adults with asthma Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 Prevalence of cardiovascular disease in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 High prevalence of undiagnosed COPD in patients with cardiovascular disease Source: Annual Congress 2009 - Risk factors for COPD Year: 2009 Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 Risk factors of acute respiratory distress syndrome: A 10-year study Source: Annual Congress 2010 - Intensive care unit outcome Year: 2010 Impact of PAP in reducing cardiovascular events in OSA patients: a 10-years follow-up Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 Risk factors for lung involvements in patients with Sjögren's syndrome Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Respiratory polygraphy patterns and risk of cardiovascular events in patients with acute coronary syndrome Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021 The cardiovascular  comorbidity and the risk of stroke by means of CHADS2- VASc scale  in patients with chronic obstructive pulmonary disease. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Burden of comorbidities in patients with OSA and COPD-OSA overlap syndrome Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020